๐Ÿ‘ค Katsunobu Shigematsu

๐Ÿ” Search ๐Ÿ“‹ Browse ๐Ÿท๏ธ Tags โค๏ธ Favourites โž• Add ๐Ÿงฌ Extraction
2
Articles
2
Name variants
Also published as: Lisa Shigematsu
articles

Acquisition of

Naoki Fukunaga, Hideki Terai, Rui Nomura +17 more ยท 2025 ยท JTO clinical and research reports ยท Elsevier ยท added 2026-04-24
Histologic transformation from adenocarcinoma to SCLC is a recognized mechanism of resistance in lung cancer. However, the transformation into squamous cell carcinoma is less common, and the associate Show more
Histologic transformation from adenocarcinoma to SCLC is a recognized mechanism of resistance in lung cancer. However, the transformation into squamous cell carcinoma is less common, and the associated genomic alterations remain unclear. Here, we present a case of lung adenocarcinoma harboring an EGFR ( Show less
๐Ÿ“„ PDF DOI: 10.1016/j.jtocrr.2025.100862
FGFR1
Manar A Elhinnawi, Yukari Okita, Katsunobu Shigematsu +7 more ยท 2025 ยท Cancer science ยท Blackwell Publishing ยท added 2026-04-24
Breast cancer is a heterogeneous disease and is one of the most prevalent cancers in women. Triple-negative breast cancer (TNBC) is a relatively aggressive subtype of breast cancer, which is difficult Show more
Breast cancer is a heterogeneous disease and is one of the most prevalent cancers in women. Triple-negative breast cancer (TNBC) is a relatively aggressive subtype of breast cancer, which is difficult to treat. Glycoprotein nonmetastatic melanoma protein B (GPNMB) is a type I transmembrane protein that is overexpressed in various types of cancers, including breast cancer, especially TNBC. In this study, bioinformatic analyses revealed enhanced fibroblast growth factor receptor 1 (FGFR1) signaling in patients with invasive breast cancer, and the GPNMB Show less
๐Ÿ“„ PDF DOI: 10.1111/cas.16419
FGFR1